Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection

Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. al...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of investigative dermatology 2005-07, Vol.125 (1), p.108-115
Hauptverfasser: López-García, Belén, Lee, Phillip H.A., Yamasaki, Kenshi, Gallo, Richard L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 115
container_issue 1
container_start_page 108
container_title Journal of investigative dermatology
container_volume 125
creator López-García, Belén
Lee, Phillip H.A.
Yamasaki, Kenshi
Gallo, Richard L.
description Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.
doi_str_mv 10.1111/j.0022-202X.2005.23713.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67981337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X15323514</els_id><sourcerecordid>1044440291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</originalsourceid><addsrcrecordid>eNqFkV1LHDEYhUNp0a31L5TgRe9mzMd8ZC63i9sKgqVV6F3IJG8062xikxnRf9-Muyh4Y25CwnPOy3sOQpiSkuZzuikJYaxghP0tGSF1yXhLefn4AS1ozXhB26r9iBYv0CH6nNKGENpUtThAh7TuBOOULJBa-tEV68nfqAEv9ege3PiEg8UrNd7C4LQzziesvMH57SL-FUbIkkz_DgNg5zPpjTMKq6F3WmX4z13-PfcWsl3wX9Anq4YEx_v7CF2vz65WP4uLyx_nq-VFoStBxkLRTiluoFG8rixpRKWoEYKZlgsLhHdAgOumY5W1pmetqHvbcdo3qu6J1pwfoW873_sY_k2QRrl1ScMwKA9hSrJpO0E5b98FaeaqmooMnrwBN2GKPi8hGSU58Y7PY8UO0jGkFMHK--i2Kj5JSuRcltzIuQc59yDnsuRzWfIxS7_u_ad-C-ZVuG8nA993AOTcHhxEmbQDr8G4mMOVJrj3p_wHVqeldA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210371933</pqid></control><display><type>article</type><title>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>ProQuest Central</source><creator>López-García, Belén ; Lee, Phillip H.A. ; Yamasaki, Kenshi ; Gallo, Richard L.</creator><creatorcontrib>López-García, Belén ; Lee, Phillip H.A. ; Yamasaki, Kenshi ; Gallo, Richard L.</creatorcontrib><description>Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.</description><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1111/j.0022-202X.2005.23713.x</identifier><identifier>PMID: 15982310</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; anti-microbial peptides ; Antifungal Agents - pharmacology ; Antimicrobial Cationic Peptides - metabolism ; Candida albicans ; Candida albicans - drug effects ; Candidiasis, Cutaneous - physiopathology ; defensins ; Humans ; In Vitro Techniques ; infection ; innate immunity ; LL-37 ; mCRAMP ; Mice ; sweat</subject><ispartof>Journal of investigative dermatology, 2005-07, Vol.125 (1), p.108-115</ispartof><rights>2005 The Society for Investigative Dermatology, Inc</rights><rights>Copyright Nature Publishing Group Jul 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</citedby><cites>FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/210371933?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15982310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>López-García, Belén</creatorcontrib><creatorcontrib>Lee, Phillip H.A.</creatorcontrib><creatorcontrib>Yamasaki, Kenshi</creatorcontrib><creatorcontrib>Gallo, Richard L.</creatorcontrib><title>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><description>Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.</description><subject>Animals</subject><subject>anti-microbial peptides</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antimicrobial Cationic Peptides - metabolism</subject><subject>Candida albicans</subject><subject>Candida albicans - drug effects</subject><subject>Candidiasis, Cutaneous - physiopathology</subject><subject>defensins</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>infection</subject><subject>innate immunity</subject><subject>LL-37</subject><subject>mCRAMP</subject><subject>Mice</subject><subject>sweat</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkV1LHDEYhUNp0a31L5TgRe9mzMd8ZC63i9sKgqVV6F3IJG8062xikxnRf9-Muyh4Y25CwnPOy3sOQpiSkuZzuikJYaxghP0tGSF1yXhLefn4AS1ozXhB26r9iBYv0CH6nNKGENpUtThAh7TuBOOULJBa-tEV68nfqAEv9ege3PiEg8UrNd7C4LQzziesvMH57SL-FUbIkkz_DgNg5zPpjTMKq6F3WmX4z13-PfcWsl3wX9Anq4YEx_v7CF2vz65WP4uLyx_nq-VFoStBxkLRTiluoFG8rixpRKWoEYKZlgsLhHdAgOumY5W1pmetqHvbcdo3qu6J1pwfoW873_sY_k2QRrl1ScMwKA9hSrJpO0E5b98FaeaqmooMnrwBN2GKPi8hGSU58Y7PY8UO0jGkFMHK--i2Kj5JSuRcltzIuQc59yDnsuRzWfIxS7_u_ad-C-ZVuG8nA993AOTcHhxEmbQDr8G4mMOVJrj3p_wHVqeldA</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>López-García, Belén</creator><creator>Lee, Phillip H.A.</creator><creator>Yamasaki, Kenshi</creator><creator>Gallo, Richard L.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20050701</creationdate><title>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</title><author>López-García, Belén ; Lee, Phillip H.A. ; Yamasaki, Kenshi ; Gallo, Richard L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>anti-microbial peptides</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antimicrobial Cationic Peptides - metabolism</topic><topic>Candida albicans</topic><topic>Candida albicans - drug effects</topic><topic>Candidiasis, Cutaneous - physiopathology</topic><topic>defensins</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>infection</topic><topic>innate immunity</topic><topic>LL-37</topic><topic>mCRAMP</topic><topic>Mice</topic><topic>sweat</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López-García, Belén</creatorcontrib><creatorcontrib>Lee, Phillip H.A.</creatorcontrib><creatorcontrib>Yamasaki, Kenshi</creatorcontrib><creatorcontrib>Gallo, Richard L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López-García, Belén</au><au>Lee, Phillip H.A.</au><au>Yamasaki, Kenshi</au><au>Gallo, Richard L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>125</volume><issue>1</issue><spage>108</spage><epage>115</epage><pages>108-115</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><abstract>Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15982310</pmid><doi>10.1111/j.0022-202X.2005.23713.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-202X
ispartof Journal of investigative dermatology, 2005-07, Vol.125 (1), p.108-115
issn 0022-202X
1523-1747
language eng
recordid cdi_proquest_miscellaneous_67981337
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library; ProQuest Central
subjects Animals
anti-microbial peptides
Antifungal Agents - pharmacology
Antimicrobial Cationic Peptides - metabolism
Candida albicans
Candida albicans - drug effects
Candidiasis, Cutaneous - physiopathology
defensins
Humans
In Vitro Techniques
infection
innate immunity
LL-37
mCRAMP
Mice
sweat
title Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Fungal%20Activity%20of%20Cathelicidins%20and%20their%20Potential%20Role%20in%20Candida%20albicans%20Skin%20Infection&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=L%C3%B3pez-Garc%C3%ADa,%20Bel%C3%A9n&rft.date=2005-07-01&rft.volume=125&rft.issue=1&rft.spage=108&rft.epage=115&rft.pages=108-115&rft.issn=0022-202X&rft.eissn=1523-1747&rft_id=info:doi/10.1111/j.0022-202X.2005.23713.x&rft_dat=%3Cproquest_cross%3E1044440291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=210371933&rft_id=info:pmid/15982310&rft_els_id=S0022202X15323514&rfr_iscdi=true